Terms: = Lung cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
32 results:
1. High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line.
Wang S; Oliveira-Silveira J; Fang G; Kang J
BMC Cancer; 2024 Mar; 24(1):335. PubMed ID: 38475728
[TBL] [Abstract] [Full Text] [Related]
2. Identification of molecular subtypes and prognostic model to reveal immune infiltration and predict prognosis based on immunogenic cell death-related genes in lung adenocarcinoma.
Dong Y; Yu X; Song H; Chen Q; Zheng B; Ji X; Xu M; Liu J; Sun X; Wang Q; Ren R; Lu H
Cell Cycle; 2023; 22(23-24):2566-2583. PubMed ID: 38164943
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation.
Li Z; Huang Y; Zhou R; Li Z; Yan Q
Medicine (Baltimore); 2023 Jul; 102(29):e34312. PubMed ID: 37478236
[TBL] [Abstract] [Full Text] [Related]
4. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract] [Full Text] [Related]
5. EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries.
Elshatlawy M; Sampson J; Clarke K; Bayliss R
Mol Oncol; 2023 Jun; 17(6):950-963. PubMed ID: 37149843
[TBL] [Abstract] [Full Text] [Related]
6. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced prognosis in cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
7. Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating hsp90 activity.
Byun JK; Lee SH; Moon EJ; Park MH; Jang H; Weitzel DH; Kim HH; Basnet N; Kwon DY; Lee CT; Stephenson TN; Jeong JH; Patel BA; Park SJ; Chi JT; Dewhirst MW; Hong J; Lee YM
Br J Cancer; 2023 Apr; 128(8):1491-1502. PubMed ID: 36759727
[TBL] [Abstract] [Full Text] [Related]
8. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract] [Full Text] [Related]
10. Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells.
Ko JC; Chen JC; Hsieh JM; Tseng PY; Chiang CS; Liu LL; Chien CC; Huang IH; Chang QZ; Mu BC; Lin YW
Biochem Pharmacol; 2022 Oct; 204():115207. PubMed ID: 35961402
[TBL] [Abstract] [Full Text] [Related]
11. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.
Li W; Liu J
Front Immunol; 2022; 13():845585. PubMed ID: 35757728
[TBL] [Abstract] [Full Text] [Related]
12. Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits lung cancer Growth through the Induction of Cell Death.
Kim MJ; Ku JM; Choi YJ; Lee SY; Hong SH; Kim HI; Shin YC; Ko SG
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408505
[TBL] [Abstract] [Full Text] [Related]
13. hsp90 inhibitor gedunin causes apoptosis in A549 lung cancer cells by disrupting hsp90:Beclin-1:Bcl-2 interaction and downregulating autophagy.
Hasan A; Haque E; Hameed R; Maier PN; Irfan S; Kamil M; Nazir A; Mir SS
Life Sci; 2020 Sep; 256():118000. PubMed ID: 32585246
[TBL] [Abstract] [Full Text] [Related]
14. Direct targeting of hsp90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis.
Huang XH; Yan X; Zhang QH; Hong P; Zhang WX; Liu YP; Xu WW; Li B; He QY
Cancer Lett; 2020 Oct; 489():66-78. PubMed ID: 32544514
[TBL] [Abstract] [Full Text] [Related]
15. Heat shock proteins as biomarkers of lung cancer.
Mittal S; Rajala MS
Cancer Biol Ther; 2020 Jun; 21(6):477-485. PubMed ID: 32228356
[TBL] [Abstract] [Full Text] [Related]
16. Drug Combinatorial Therapies for the Treatment of KRAS Mutated lung cancers.
He H; Xu C; Cheng Z; Qian X; Zheng L
Curr Top Med Chem; 2019; 19(23):2128-2142. PubMed ID: 31475900
[TBL] [Abstract] [Full Text] [Related]
17. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
[TBL] [Abstract] [Full Text] [Related]
18. The targeted inhibition of hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
19. Blockade of extracellular heat shock protein 90α by 1G6-D7 attenuates pulmonary fibrosis through inhibiting ERK signaling.
Dong H; Luo L; Zou M; Huang C; Wan X; Hu Y; Le Y; Zhao H; Li W; Zou F; Cai S
Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1006-L1015. PubMed ID: 28860147
[TBL] [Abstract] [Full Text] [Related]
20. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
Saini J; Sharma PK
Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
[TBL] [Abstract] [Full Text] [Related]
[Next]
